BNP Paribas Financial Markets’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,322
| Closed | -$707 | – | 5665 |
|
|
2024
Q4 | $707 | Buy |
+1,322
| New | +$921 | ﹤0.01% | 5128 |
|
|
2022
Q4 | – | Sell |
-129
| Closed | -$858 | – | 4769 |
|
|
2022
Q3 | $858 | Buy |
+129
| New | +$794 | ﹤0.01% | 4449 |
|
|
2020
Q3 | – | Sell |
-1,546
| Closed | -$15.7K | – | 4307 |
|
|
2020
Q2 | $15.7K | Sell |
1,546
-4,571
| -75% | -$42K | ﹤0.01% | 3502 |
|
|
2020
Q1 | $49.7K | Buy |
6,117
+4,373
| +251% | +$37.9K | ﹤0.01% | 3543 |
|
|
2019
Q4 | $15.1K | Sell |
1,744
-186
| -10% | -$1.04K | ﹤0.01% | 4065 |
|
|
2019
Q3 | $11.9K | Buy |
1,930
+611
| +46% | +$4.94K | ﹤0.01% | 4115 |
|
|
2019
Q2 | $21.9K | Sell |
1,319
-1,193
| -47% | -$20.7K | ﹤0.01% | 3865 |
|
|
2019
Q1 | $42K | Buy |
2,512
+2,351
| +1,460% | +$33.9K | ﹤0.01% | 3605 |
|
|
2018
Q4 | $1.84K | Sell |
161
-137
| -46% | -$2.77K | ﹤0.01% | 3818 |
|
|
2018
Q3 | $11.9K | Hold |
298
| – | – | ﹤0.01% | 3652 |
|
|
2018
Q2 | $8.41K | Buy |
+298
| New | +$6.61K | ﹤0.01% | 3862 |
|
BNP Paribas Financial Markets's MRNS Position: Q1 2025 in Review
BNP Paribas Financial Markets sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 1,322 shares — an estimated $707 sold.
BNP Paribas Financial Markets first reported a position in MRNS in Q2 2018 and held it in 11 quarters. The position peaked at $49.7K in Q1 2020. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- BNP Paribas Financial Markets reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1,322 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $707.
- BNP Paribas Financial Markets first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 11 quarters.
- BNP Paribas Financial Markets's Marinus Pharmaceuticals, Inc position peaked at $49.7K in Q1 2020.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.